Information for Health Care Providers

Treatment Guidelines for Biological, Chemical, and Radiological Incidents

Anthrax

• Oregon Environmental Laboratory Accreditation Program (ORELAP) list of accredited laboratories
  

CDC Guidelines and Recommendations

• Anthrax Vaccine Information Statements
• Update: Considerations for distinguishing influenza-like illness from inhalational anthrax MMWR, Nov. 9, 2001, Vol. 50, No. 44
  
• Update: The anthrax investigations, and a description of adverse reactions associated with antimicrobial prophylaxis MMWR, Nov. 9, 2001, Vol. 50, No. 44
• Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax MMWR, Nov. 2, 2001, Vol. 50, No. 43
• Update: Updated Recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis MMWR, Nov. 2, 2001, Vol. 50, No. 43
• CDC Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines MMWR, Oct. 19, 2001, Vol. 50, No. 41
• Recommendations for use of anthrax vaccine in the United States MMWR, December 15, 2000, Vol. 49, No. RR-15 (pdf) (224K)
• Bioterrorism alleging use of anthrax and interim guidelines for management MMWR, February 5, 1999, Vol. 48, No. 4 (pdf) 269K

The JAMA Network

• Clinical presentation of inhalational anthrax following bioterrorism exposure: report of two surviving patients JAMA, Nov. 28, 2001, Vol. 286, No. 20
• Death due to bioterrorism-related inhalational anthrax: report of two patients JAMA, Nov. 28, 2001, Vol. 286, No. 20

Smallpox

• Oregon Public Health Division smallpox information

CDC smallpox hotline numbers:

• English —1-888-246-2675
• Spanish —1-888-246-2857
• TTY—1-866-874-2646

CDC Guidelines

• Smallpox ACIP Vaccine Recommendations (ACIP)
• Vaccine adverse events information (CDC)
• CDC Smallpox response planning 
• Smallpox Vaccine Information Statements (pdf) (FDA)
• CDC smallpox homepage

Chemical and Radiological Incidents

• Acute Chemical Emergencies (NEJM, Feb. 19, 2004)
• Recognition of illness associated with exposure to chemical agents
• Recognition of illness associated with the intentional release of a biologic agent MMWR, Oct. 19, 2001, Vol. 50, No. 41
• Laboratory information for bioterrorism emergencies (CDC)
• The Medical Letter: articles on the clinical effects, prevention and treatment of injury caused by chemical biological and nuclear weapons
•